Protagonist Therapeutics Inc. (PTGX) NASDAQ

$11.37 -0.04 (-0.31%)

Market Cap: $559.56M

As of 08/15/22 12:47 PM EDT. Market open.

(PTGX)

Protagonist Therapeutics Inc. (PTGX) NASDAQ

$11.37 -0.04 (-0.31%)

Market Cap: $559.56M

As of 08/15/22 12:47 PM EDT. Market open.

Protagonist Therapeutics is a clinical stage biopharmaceutical company with multiple peptide-based new chemical entities in different stages of development. Rusfertide (PTG-300) is an injectable hepcidin mimetic in a Phase 2 proof-of-concept clinical trial for polycythemia vera, and a separate Phase 2 clinical study for hereditary hemochromatosis. PN-943 is an orally delivered, gut-restricted ... read more

Protagonist Therapeutics is a clinical stage biopharmaceutical company with multiple peptide-based new chemical entities in different stages of development. Rusfertide (PTG-300) is an injectable hepcidin mimetic in a Phase 2 proof-of-concept clinical trial for polycythemia vera, and a separate Phase 2 clinical study for hereditary hemochromatosis. PN-943 is an orally delivered, gut-restricted alpha-4-beta-7 integrin specific antagonist peptide in a 150 patient Phase 2 study for the potential treatment of inflammatory bowel disease, with ulcerative colitis as the initial targeted indication. PTG-200 is an orally delivered, gut-restricted, interleukin-23 receptor specific antagonist peptide in a Phase 2 clinical trial for Crohn's disease. Two additional second-generation oral interleukin-23 receptor antagonist candidates PN-235 and PN-232, are in early stages of clinical development. The Company has developed a proprietary technology platform to discover and develop novel peptide-based therapeutics to address significant unmet medical needs and transform existing treatment paradigms. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
79
CEO Compensation (Base)
$520,000
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$11.10
Previous Close
$11.40
Days Range
$10.42 - $11.53
52 week range
$6.91 - $50.54
Volume
137,604
Avg. Volume (30 days)
1,077,369
Market Cap
$559.56M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
49,084,068
Open
$11.10
Previous Close
$11.40
Days Range
$10.42 - $11.53
52 week range
$6.91 - $50.54
Volume
137,604
Avg. Volume (30 days)
1,077,369
Market Cap
$559.56M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
49,084,068

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PROTAGONIST THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Waddill William D. Director May 03, 2022 Option Exercise $8.59 12,000 103,080 12,000 May 04, 2022, 08:41 PM
PATEL DINESH V PH D President and CEO May 04, 2022 Option Exercise $4.21 15,742 66,274 584,048 May 04, 2022, 08:33 PM
Gupta Suneel Chief Development Officer Apr 26, 2022 Option Exercise $7.38 40,000 295,200 117,561 Apr 26, 2022, 09:42 PM
PATEL DINESH V PH D President and CEO Apr 26, 2022 Option Exercise $4.21 30,000 126,300 568,306 Apr 26, 2022, 09:34 PM
PATEL DINESH V PH D President and CEO Apr 14, 2022 Option Exercise $1.89 34,087 64,424 537,847 Apr 14, 2022, 08:09 PM
Gupta Suneel Chief Development Officer Feb 28, 2022 Option Exercise $24.28 649 15,758 77,007 Mar 02, 2022, 08:40 PM
PATEL DINESH V PH D President and CEO Feb 28, 2022 Option Exercise $24.28 4,648 112,853 503,760 Mar 02, 2022, 08:39 PM
Liu David Y Chief Scientific Officer Feb 28, 2022 Option Exercise $24.28 2,119 51,449 66,538 Mar 02, 2022, 08:38 PM
PATEL DINESH V PH D President and CEO Dec 21, 2021 Sale $32.14 15,000 482,170 477,158 Dec 23, 2021, 04:17 PM
PATEL DINESH V PH D President and CEO Sep 21, 2021 Option Exercise $4.21 40,000 168,400 492,158 Sep 21, 2021, 09:45 PM
Liu David Y Chief Scientific Officer Aug 17, 2021 Option Exercise $0.87 10,000 8,700 73,033 Aug 19, 2021, 05:49 PM
Liu David Y Chief Scientific Officer Aug 17, 2021 Sale $47.56 14,779 702,889 58,254 Aug 19, 2021, 05:49 PM
Noonberg Sarah B. Director Feb 11, 2021 Option Exercise $6.98 3,700 25,826 3,700 Feb 12, 2021, 06:36 PM
Noonberg Sarah B. Director Feb 10, 2021 Option Exercise $6.98 4,700 32,806 4,700 Feb 12, 2021, 06:36 PM
Noonberg Sarah B. Director Feb 11, 2021 Sale $25.09 3,700 92,833 0 Feb 12, 2021, 06:36 PM
Noonberg Sarah B. Director Feb 10, 2021 Sale $25.47 4,700 119,722 400 Feb 12, 2021, 06:36 PM
PATEL DINESH V PH D President and CEO Jan 19, 2021 Option Exercise $4.21 13,000 54,730 450,990 Jan 20, 2021, 08:20 PM
PATEL DINESH V PH D President and CEO Jan 19, 2021 Sale $24.60 24,846 611,105 426,144 Jan 20, 2021, 08:20 PM
KHOSLA CHAITAN PHD Director Aug 11, 2020 Option Exercise $1.89 2,499 4,723 2,499 Aug 12, 2020, 05:38 PM
KHOSLA CHAITAN PHD Director Aug 11, 2020 Sale $17.19 2,499 42,952 0 Aug 12, 2020, 05:38 PM
PATEL DINESH V PH D President and CEO Mar 20, 2020 Option Exercise $1.89 10,000 18,900 439,990 Mar 23, 2020, 06:14 PM
PATEL DINESH V PH D President and CEO Mar 12, 2020 Option Exercise $1.16 18,344 21,279 429,990 Mar 13, 2020, 01:04 PM
SELICK HAROLD E Director Mar 12, 2020 Buy $6.70 12,000 80,400 15,310 Mar 12, 2020, 07:26 PM
Giraudo Bryan Director Dec 03, 2019 Buy $5.70 8,000 45,620 8,000 Dec 03, 2019, 06:46 PM
Gupta Suneel EVP Clinical Operations Dec 03, 2019 Buy $5.13 30,000 153,900 49,500 Dec 03, 2019, 06:32 PM
Kalkofen Donald A. Chief Financial Officer Dec 03, 2019 Buy $5.10 1,175 5,987 1,175 Dec 03, 2019, 06:11 PM
PATEL DINESH V PH D President and CEO Dec 03, 2019 Buy $5.62 30,000 168,500 409,824 Dec 03, 2019, 06:10 PM
PATEL DINESH V PH D President and CEO Nov 26, 2019 Option Exercise $1.16 4,000 4,640 379,824 Nov 27, 2019, 02:58 PM
Liu David Y Chief Scientific Officer Aug 06, 2019 Sale $8.85 3,395 30,044 49,802 Aug 08, 2019, 06:17 PM
PATEL DINESH V PH D President and CEO Aug 06, 2019 Sale $8.85 10,792 95,535 374,792 Aug 08, 2019, 06:15 PM
SELICK HAROLD E Director Apr 01, 2019 Option Exercise $1.31 3,310 4,336 3,310 Apr 02, 2019, 07:19 PM
Liu David Y Chief Scientific Officer Mar 01, 2019 Sale $8.03 810 6,504 51,197 Mar 04, 2019, 06:35 PM
PATEL DINESH V PH D President and CEO Mar 01, 2019 Sale $8.03 2,183 17,529 383,831 Mar 04, 2019, 06:33 PM
Shames Richard S. Chief Medical Officer Mar 01, 2019 Sale $8.03 657 5,276 32,021 Mar 04, 2019, 06:29 PM
PATEL DINESH V PH D President and CEO Feb 06, 2019 Sale $7.74 10,909 84,410 367,396 Feb 08, 2019, 05:37 PM
Liu David Y Chief Scientific Officer Feb 06, 2019 Sale $7.74 3,821 29,562 37,007 Feb 08, 2019, 05:30 PM
Shames Richard S. Chief Medical Officer Feb 06, 2019 Sale $7.74 2,778 21,506 26,758 Feb 08, 2019, 05:27 PM
PATEL DINESH V PH D President and CEO Jan 11, 2019 Option Exercise $1.16 22,344 25,919 368,173 Jan 14, 2019, 07:00 PM
CANAAN X L.P. 10% Owner May 17, 2018 Sale $6.09 38,968 237,358 2,116,552 May 21, 2018, 04:34 PM
Giraudo Bryan Director May 16, 2017 Buy $6.46 10,000 64,566 10,000 May 17, 2018, 05:48 PM
CANAAN X L.P. 10% Owner May 16, 2018 Sale $6.46 29,441 190,071 2,155,520 May 16, 2018, 05:16 PM
CANAAN X L.P. 10% Owner May 15, 2018 Sale $6.48 57,715 374,080 2,184,961 May 16, 2018, 05:16 PM
CANAAN X L.P. 10% Owner May 14, 2018 Sale $6.37 77,591 494,224 2,242,676 May 16, 2018, 05:16 PM
PATEL DINESH V PH D President and CEO May 10, 2018 Option Exercise $1.16 13,516 15,679 265,779 May 11, 2018, 06:50 PM
PATEL DINESH V PH D President and CEO Apr 02, 2018 Option Exercise $1.16 20,000 23,200 252,263 Apr 03, 2018, 05:17 PM
PATEL DINESH V PH D President and CEO Mar 26, 2018 Option Exercise $0.87 11,298 9,829 232,263 Mar 28, 2018, 05:20 PM
CANAAN X L.P. 10% Owner Mar 23, 2018 Sale $20.71 59,950 1,241,325 2,320,267 Mar 26, 2018, 04:25 PM
CANAAN X L.P. 10% Owner Mar 20, 2018 Sale $20.61 17,060 351,538 2,402,675 Mar 22, 2018, 05:33 PM
CANAAN X L.P. 10% Owner Mar 22, 2018 Sale $20.62 4,759 98,133 2,380,217 Mar 22, 2018, 05:33 PM
CANAAN X L.P. 10% Owner Mar 21, 2018 Sale $20.61 17,699 364,727 2,384,976 Mar 22, 2018, 05:33 PM
CANAAN X L.P. 10% Owner Mar 19, 2018 Sale $20.57 13,439 276,446 2,419,735 Mar 19, 2018, 05:22 PM
CANAAN X L.P. 10% Owner Mar 16, 2018 Sale $20.51 6,926 142,063 2,433,174 Mar 19, 2018, 05:22 PM
CANAAN X L.P. 10% Owner Mar 13, 2018 Sale $20.84 1,204 25,094 2,452,051 Mar 15, 2018, 04:55 PM
CANAAN X L.P. 10% Owner Mar 15, 2018 Sale $20.64 11,751 242,521 2,440,100 Mar 15, 2018, 04:55 PM
CANAAN X L.P. 10% Owner Mar 14, 2018 Sale $20.77 200 4,154 2,451,851 Mar 15, 2018, 04:55 PM
Liu David Y Chief Scientific Officer Mar 12, 2018 Option Exercise $4.21 3,500 14,735 18,528 Mar 13, 2018, 04:48 PM
Liu David Y Chief Scientific Officer Mar 12, 2018 Sale $21.29 3,500 74,500 15,028 Mar 13, 2018, 04:48 PM
Liu David Y Chief Scientific Officer Mar 02, 2018 Option Exercise $1.89 875 1,654 14,197 Mar 02, 2018, 07:17 PM
Liu David Y Chief Scientific Officer Mar 02, 2018 Sale $20.00 875 17,500 13,322 Mar 02, 2018, 07:17 PM
Liu David Y Chief Scientific Officer Jan 16, 2018 Option Exercise $1.89 875 1,654 4,697 Jan 17, 2018, 04:34 PM
Liu David Y Chief Scientific Officer Jan 16, 2018 Sale $20.00 875 17,500 3,822 Jan 17, 2018, 04:34 PM
Shames Richard S. Chief Medical Officer Dec 22, 2017 Option Exercise $4.21 3,529 14,857 3,529 Dec 27, 2017, 02:07 PM
Shames Richard S. Chief Medical Officer Dec 22, 2017 Sale $20.50 3,529 72,345 0 Dec 27, 2017, 02:07 PM
PATEL DINESH V PH D President and CEO Dec 21, 2017 Option Exercise $1.89 8,210 15,517 198,647 Dec 21, 2017, 07:54 PM
PATEL DINESH V PH D President and CEO Dec 21, 2017 Sale $19.56 8,210 160,570 190,437 Dec 21, 2017, 07:54 PM
PATEL DINESH V PH D President and CEO Dec 20, 2017 Option Exercise $1.89 1,790 3,383 192,227 Dec 20, 2017, 09:28 PM
PATEL DINESH V PH D President and CEO Dec 20, 2017 Sale $19.55 1,790 34,987 190,437 Dec 20, 2017, 09:28 PM
Liu David Y Chief Scientific Officer Dec 18, 2017 Option Exercise $1.89 875 1,654 4,697 Dec 20, 2017, 09:13 PM
Liu David Y Chief Scientific Officer Dec 18, 2017 Sale $20.00 875 17,500 3,822 Dec 20, 2017, 09:13 PM
O'Neil Thomas P. Chief Financial Officer Dec 18, 2017 Option Exercise $2.69 8,000 21,480 8,000 Dec 20, 2017, 09:08 PM
O'Neil Thomas P. Chief Financial Officer Dec 18, 2017 Sale $20.00 8,000 160,000 0 Dec 20, 2017, 09:08 PM
Liu David Y Chief Scientific Officer Nov 30, 2017 Option Exercise $1.89 875 1,654 4,697 Dec 01, 2017, 06:56 PM
Liu David Y Chief Scientific Officer Nov 30, 2017 Sale $20.00 875 17,500 3,822 Dec 01, 2017, 06:56 PM
Liu David Y Chief Scientific Officer Nov 13, 2017 Option Exercise $3.05 7,000 21,350 7,322 Nov 15, 2017, 07:14 PM
Liu David Y Chief Scientific Officer Nov 13, 2017 Sale $16.97 7,000 118,761 3,822 Nov 15, 2017, 07:14 PM
Shames Richard S. Chief Medical Officer Oct 05, 2017 Option Exercise $4.21 2,017 8,492 2,017 Oct 10, 2017, 07:04 PM
Shames Richard S. Chief Medical Officer Oct 05, 2017 Sale $19.00 2,017 38,323 0 Oct 10, 2017, 07:04 PM
Shames Richard S. Chief Medical Officer Sep 12, 2017 Sale $14.31 3,687 52,753 0 Sep 12, 2017, 07:50 PM
Shames Richard S. Chief Medical Officer Aug 29, 2017 Option Exercise $4.21 1,512 6,366 3,377 Aug 30, 2017, 07:08 PM
Shames Richard S. Chief Medical Officer Aug 29, 2017 Sale $17.00 1,512 25,704 1,865 Aug 30, 2017, 07:08 PM
Liu David Y Chief Scientific Officer Aug 28, 2017 Option Exercise $4.21 3,500 14,735 5,500 Aug 29, 2017, 07:48 PM
Liu David Y Chief Scientific Officer Aug 28, 2017 Sale $15.00 3,500 52,500 2,000 Aug 29, 2017, 07:48 PM
Liu David Y Chief Scientific Officer Jul 10, 2017 Option Exercise $1.89 3,500 6,615 5,500 Jul 12, 2017, 05:55 PM
Liu David Y Chief Scientific Officer Jul 10, 2017 Sale $12.68 3,500 44,380 2,000 Jul 12, 2017, 05:55 PM
PATEL DINESH V PH D President and CEO May 09, 2017 Option Exercise $1.16 19,099 22,155 190,437 May 10, 2017, 08:44 PM
PATEL DINESH V PH D President and CEO Apr 06, 2017 Option Exercise $1.16 20,000 23,200 171,338 Apr 07, 2017, 09:24 PM
PATEL DINESH V PH D President and CEO Mar 10, 2017 Option Exercise $0.87 16,362 14,235 151,338 Mar 13, 2017, 07:24 PM
JOHNSON & JOHNSON 10% Owner Aug 16, 2016 Buy $12.00 583,333 6,999,996 2,449,183 Aug 18, 2016, 05:11 PM
Papanek Julie Director Aug 16, 2016 Buy $12.00 583,333 6,999,996 2,453,255 Aug 16, 2016, 06:30 PM
CANAAN X L.P. Director Aug 16, 2016 Buy $12.00 583,333 6,999,996 2,453,255 Aug 16, 2016, 06:28 PM
Shanafelt Armen Director Aug 16, 2016 Buy $12.00 583,333 6,999,996 2,099,482 Aug 16, 2016, 06:20 PM
LV Management Group, LLC 10% Owner Aug 16, 2016 Buy $12.00 583,333 6,999,996 2,099,482 Aug 16, 2016, 06:19 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Waddill William D. Director 05/03/2022 103,080
PATEL DINESH V PH D President and CEO 05/04/2022 66,274
Gupta Suneel Chief Development Officer 04/26/2022 295,200
PATEL DINESH V PH D President and CEO 04/26/2022 126,300
PATEL DINESH V PH D President and CEO 04/14/2022 64,424
Gupta Suneel Chief Development Officer 02/28/2022 15,758
PATEL DINESH V PH D President and CEO 02/28/2022 112,853
Liu David Y Chief Scientific Officer 02/28/2022 51,449
PATEL DINESH V PH D President and CEO 12/21/2021 482,170
PATEL DINESH V PH D President and CEO 09/21/2021 168,400
Liu David Y Chief Scientific Officer 08/17/2021 8,700
Liu David Y Chief Scientific Officer 08/17/2021 702,889
Noonberg Sarah B. Director 02/11/2021 25,826
Noonberg Sarah B. Director 02/10/2021 32,806
Noonberg Sarah B. Director 02/11/2021 92,833
Noonberg Sarah B. Director 02/10/2021 119,722
PATEL DINESH V PH D President and CEO 01/19/2021 54,730
PATEL DINESH V PH D President and CEO 01/19/2021 611,105
KHOSLA CHAITAN PHD Director 08/11/2020 4,723
KHOSLA CHAITAN PHD Director 08/11/2020 42,952
PATEL DINESH V PH D President and CEO 03/20/2020 18,900
PATEL DINESH V PH D President and CEO 03/12/2020 21,279
SELICK HAROLD E Director 03/12/2020 80,400
Giraudo Bryan Director 12/03/2019 45,620
Gupta Suneel EVP Clinical Operations 12/03/2019 153,900
Kalkofen Donald A. Chief Financial Officer 12/03/2019 5,987
PATEL DINESH V PH D President and CEO 12/03/2019 168,500
PATEL DINESH V PH D President and CEO 11/26/2019 4,640
Liu David Y Chief Scientific Officer 08/06/2019 30,044
PATEL DINESH V PH D President and CEO 08/06/2019 95,535
SELICK HAROLD E Director 04/01/2019 4,336
Liu David Y Chief Scientific Officer 03/01/2019 6,504
PATEL DINESH V PH D President and CEO 03/01/2019 17,529
Shames Richard S. Chief Medical Officer 03/01/2019 5,276
PATEL DINESH V PH D President and CEO 02/06/2019 84,410
Liu David Y Chief Scientific Officer 02/06/2019 29,562
Shames Richard S. Chief Medical Officer 02/06/2019 21,506
PATEL DINESH V PH D President and CEO 01/11/2019 25,919
CANAAN X L.P. 10% Owner 05/17/2018 237,358
Giraudo Bryan Director 05/16/2017 64,566
CANAAN X L.P. 10% Owner 05/16/2018 190,071
CANAAN X L.P. 10% Owner 05/15/2018 374,080
CANAAN X L.P. 10% Owner 05/14/2018 494,224
PATEL DINESH V PH D President and CEO 05/10/2018 15,679
PATEL DINESH V PH D President and CEO 04/02/2018 23,200
PATEL DINESH V PH D President and CEO 03/26/2018 9,829
CANAAN X L.P. 10% Owner 03/23/2018 1,241,325
CANAAN X L.P. 10% Owner 03/20/2018 351,538
CANAAN X L.P. 10% Owner 03/22/2018 98,133
CANAAN X L.P. 10% Owner 03/21/2018 364,727
CANAAN X L.P. 10% Owner 03/19/2018 276,446
CANAAN X L.P. 10% Owner 03/16/2018 142,063
CANAAN X L.P. 10% Owner 03/13/2018 25,094
CANAAN X L.P. 10% Owner 03/15/2018 242,521
CANAAN X L.P. 10% Owner 03/14/2018 4,154
Liu David Y Chief Scientific Officer 03/12/2018 14,735
Liu David Y Chief Scientific Officer 03/12/2018 74,500
Liu David Y Chief Scientific Officer 03/02/2018 1,654
Liu David Y Chief Scientific Officer 03/02/2018 17,500
Liu David Y Chief Scientific Officer 01/16/2018 1,654
Liu David Y Chief Scientific Officer 01/16/2018 17,500
Shames Richard S. Chief Medical Officer 12/22/2017 14,857
Shames Richard S. Chief Medical Officer 12/22/2017 72,345
PATEL DINESH V PH D President and CEO 12/21/2017 15,517
PATEL DINESH V PH D President and CEO 12/21/2017 160,570
PATEL DINESH V PH D President and CEO 12/20/2017 3,383
PATEL DINESH V PH D President and CEO 12/20/2017 34,987
Liu David Y Chief Scientific Officer 12/18/2017 1,654
Liu David Y Chief Scientific Officer 12/18/2017 17,500
O'Neil Thomas P. Chief Financial Officer 12/18/2017 21,480
O'Neil Thomas P. Chief Financial Officer 12/18/2017 160,000
Liu David Y Chief Scientific Officer 11/30/2017 1,654
Liu David Y Chief Scientific Officer 11/30/2017 17,500
Liu David Y Chief Scientific Officer 11/13/2017 21,350
Liu David Y Chief Scientific Officer 11/13/2017 118,761
Shames Richard S. Chief Medical Officer 10/05/2017 8,492
Shames Richard S. Chief Medical Officer 10/05/2017 38,323
Shames Richard S. Chief Medical Officer 09/12/2017 52,753
Shames Richard S. Chief Medical Officer 08/29/2017 6,366
Shames Richard S. Chief Medical Officer 08/29/2017 25,704
Liu David Y Chief Scientific Officer 08/28/2017 14,735
Liu David Y Chief Scientific Officer 08/28/2017 52,500
Liu David Y Chief Scientific Officer 07/10/2017 6,615
Liu David Y Chief Scientific Officer 07/10/2017 44,380
PATEL DINESH V PH D President and CEO 05/09/2017 22,155
PATEL DINESH V PH D President and CEO 04/06/2017 23,200
PATEL DINESH V PH D President and CEO 03/10/2017 14,235
JOHNSON & JOHNSON 10% Owner 08/16/2016 6,999,996
Papanek Julie Director 08/16/2016 6,999,996
CANAAN X L.P. Director 08/16/2016 6,999,996
Shanafelt Armen Director 08/16/2016 6,999,996
LV Management Group, LLC 10% Owner 08/16/2016 6,999,996
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
09/30/2021
6.99%
3Q
06/30/2022
06/30/2021
9.78%
4Q
06/30/2022
03/31/2021
10.58%
5Q
06/30/2022
12/31/2020
42.17%
6Q
06/30/2022
09/30/2020
49.79%
7Q
Load More

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
6.99%
3Q
06/30/2021
9.78%
4Q
03/31/2021
10.58%
5Q
12/31/2020
42.17%
6Q
09/30/2020
49.79%
7Q
Load More